Browse grants
Federal and state grant opportunities with plain-English eligibility summaries. We aggregate public records — always verify the details on the funder’s site before applying. Or browse the complete index →
Limited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)
Due Jan 26, 2029National Institutes of Health · $25K–$250K
This NIH S10 instrumentation grant funds resource-limited institutions to purchase state-of-the-art scientific instruments supporting biomedical research and education. It is a limited competition that invites applications only from eligible organizations, and awards range from about $25,000 to $250,000. Foreign organizations and foreign components of U.S. organizations are not eligible to apply.
Schools & universitiesResearchersNarrow eligibilityBiomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)
Due Jan 29, 2029National Institutes of Health · Amount varies
This NIH/NIGMS RM1 grant funds Biomedical Technology Optimization and Dissemination Centers to refine late-stage research technologies and sustainably share them with the wider biomedical research community. Applicants should be leaders in their technology field and within the NIGMS mission. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components within a project may be allowed.
ResearchersSchools & universitiesNarrow eligibilityMaximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI)
Due Feb 6, 2029National Institutes of Health · Amount varies
This NIH/NIGMS award (MIRA for Early Stage Investigators) funds early-career biomedical researchers at U.S. institutions to run an independent research program aligned with the NIGMS mission. It is aimed at Early Stage Investigators, so it is restrictive by career stage. Non-U.S. (foreign) institutions and foreign components of U.S. organizations are not eligible to apply, though foreign components within projects may be allowed per NIH policy.
ResearchersSchools & universitiesNarrow eligibilityHEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)
Due Feb 9, 2029National Institutes of Health · Amount varies
This NIH HEAL Initiative R61/R33 grant funds action-oriented research that translates addiction epidemiology, prevention, treatment, and recovery findings into practice to address the opioid crisis and overdose. Projects can target individual, provider, organizational, community, or system levels. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components within a project may be allowed.
ResearchersSchools & universitiesNarrow eligibilityHEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Due Feb 20, 2029National Institutes of Health · Amount varies
This NIH HEAL Initiative UG3/UH3 cooperative agreement funds preclinical optimization and development of safe, non-addictive small-molecule and biologic therapeutics for treating pain, advancing candidates toward Phase II trials. Applicants must already have a promising lead candidate, a strong biological rationale, and established assays. Foreign organizations and foreign components of U.S. organizations are not eligible to apply.
ResearchersSmall businessSchools & universitiesNarrow eligibilityResearch Grants in Clinical Informatics (R01 Clinical Trial Optional)
Due Mar 5, 2029National Institutes of Health · Up to $250K
This NIH/NLM R01 grant funds research teams developing and evaluating clinical informatics tools and methods that turn health data (such as electronic health records, clinical notes, and imaging) into actionable knowledge. Both U.S. and foreign organizations are eligible to apply, but applications involving funded foreign subawards/subcontracts will be rejected under NIH's post-May-2025 policy. The award ceiling is up to about $250,000.
ResearchersSchools & universitiesBroad eligibilityAdvancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)
Due Mar 5, 2029National Institutes of Health · Up to $250K
This NIH/NLM R01 grant supports research advancing bioinformatics, translational bioinformatics, and computational biology, including AI and machine-learning methods for interpreting large biological datasets. Both U.S. and foreign organizations may apply, but applications that include funded foreign subawards/subcontracts will be deemed noncompliant and not considered. The award ceiling is up to about $250,000.
ResearchersSchools & universitiesBroad eligibilityPaul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)
Due Mar 12, 2029National Institutes of Health · Amount varies
This NIH (K12) career development award supports institutions in training clinician-scientists for clinical and translational cancer research. It is an institutional mentored program; scholars may gain experience in a mentor-led clinical trial but may not lead an independent clinical trial. Only domestic U.S. organizations may apply, foreign organizations are not eligible, though foreign components are allowed. It primarily suits academic medical centers and research institutions building oncology research careers.
Schools & universitiesResearchersNarrow eligibilityMathematical Sciences Research Institutes
Due Mar 14, 2029U.S. National Science Foundation · $1.5M–$6.5M
This National Science Foundation program funds Mathematical Sciences Research Institutes as national resources that advance research in mathematics and statistics and broaden participation, with awards ranging roughly from $1.5 million to $6.5 million. Only U.S.-based non-profit non-academic research organizations and accredited institutions of higher education may apply; multi-institutional consortia are allowed but one entity must take overall management responsibility. Individuals and for-profit firms are not eligible.
Schools & universitiesNonprofitsResearchersLarge award+1 moreScience Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)
Due Mar 16, 2029National Institutes of Health · Amount varies
This NIH (R03) award helps investigators enter high-priority substance use research, including HIV comorbidity, by funding the collection of preliminary data to support future larger grants and career advancement. Eligibility is comparatively open for NIH: foreign organizations and foreign components of U.S. organizations are both eligible to apply, and foreign components are allowed. It suits researchers and institutions transitioning into substance use research fields. No specific award amount is listed.
ResearchersSchools & universitiesARMY APPLICATIONS LAB BROAD AGENCY ANNOUNCEMENT FOR DISRUPTIVE APPLICATIONS
Due Apr 4, 2029Dept of the Army -- Materiel Command · Amount varies
The Army Applications Lab Broad Agency Announcement funds basic and applied scientific research in defense-relevant areas described in the BAA. Eligibility is unusually broad: institutions of higher education, nonprofits, state and local governments, foreign organizations and public entities, and for-profit businesses (large and small) may all apply. No specific award amount is listed, and projects are selected through full and open competition, so applicants should review the BAA's stated research areas of interest.
ResearchersSmall businessNonprofitsSchools & universities+2 morePredoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)
Due Apr 8, 2029National Institutes of Health · Amount varies
This NIH Predoctoral-to-Postdoctoral Transition Award (F99/K00) supports promising graduate students as they finish doctoral research and move into mentored postdoctoral career development, in NIH mission-relevant fields. It is a mentored training award administered through institutions; candidates may not lead an independent clinical trial but may participate in a sponsor-led one. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed.
Schools & universitiesResearchersNarrow eligibilityNIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed)
Due May 5, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25/UE5) funds mentoring activities and networks that develop the biomedical, behavioral, and clinical research workforce. It requires institutional commitment of staff, facilities, and resources, and proposed activities must be distinct from any existing federally funded training programs (such as T32) at the applicant. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed)
Due May 5, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25) funds hands-on research experiences that help build and diversify the biomedical, behavioral, and clinical research workforce. It is aimed at institutions that can provide the staff, facilities, and educational resources to run such programs, and proposed activities must be distinct from any existing federally funded training grants (such as T32). Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)
Due May 7, 2029National Institutes of Health · Amount varies
This NIH parent opportunity supports research projects built around international collaborations between a U.S. (domestic prime) organization and foreign partners, and at least one international subproject is required. Only domestic U.S. organizations may apply as the prime; non-U.S. entities cannot apply directly, though funded foreign components are allowed. It is aimed at research institutions and universities pursuing health-related projects that need talent, populations, or resources found in other countries. Applicants should expect to manage a linked prime-and-foreign-subaward structure.
Schools & universitiesResearchersNarrow eligibilityBiological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)
Due May 7, 2029National Institutes of Health · Amount varies
This NIH (X01) opportunity does not provide cash funding but instead grants investigators access to services from a state-of-the-art Biological Testing Facility to advance contraceptive development or reproductive health research. Applicants do not need current NIH funding, though priority may go to programs already receiving NIH support. Notably, foreign organizations are eligible to apply, but foreign components of U.S. organizations and foreign components in general are not allowed. It suits researchers needing specialized biological testing resources.
ResearchersSchools & universitiesNarrow eligibilityCoordinating Austere Nodes through Virtualization and Analysis of Streams (CANVAS)
Due May 22, 2029Air Force -- Research Lab · Up to $24.9M
This Air Force Research Laboratory opportunity (CANVAS) funds research on coordinating austere/edge computing nodes through virtualization and analysis of data streams, with a ceiling reported up to roughly $24.9 million. No Grants.gov submissions are accepted; all applications must follow the instructions in the linked SAM.gov announcement, which also holds the full eligibility details. Prospective applicants must review the SAM.gov notice to determine whether they qualify.
ResearchersLarge awardNIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH/NIAID Program Project (P01) opportunity funds multi-component research programs in infectious disease and immunology, including HIV, immune dysfunction, allergy, autoimmunity, and vaccine/therapeutic/diagnostic development. Each application must include at least two related research projects plus an administrative core, so it is geared toward research institutions with established teams. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed. Clinical trials are not permitted under this NOFO.
Schools & universitiesResearchersNarrow eligibilityNIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25) funds the development of courses, curricula, and educational methods that strengthen the biomedical, behavioral, and clinical research workforce. It is aimed at institutions that can commit staff, facilities, and educational resources, and proposed activities must be distinct from any existing federally funded training grants (such as T32) at the applicant. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH/NIAID Resource-Related Research Project (R24) opportunity funds the creation or support of shared scientific resources that benefit high-priority research in infectious disease and immunology. NIAID expects to use it infrequently, only when other funding mechanisms are not appropriate, so it is a narrow opportunity for research institutions. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed, and clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibility